Countries with higher colorectal cancer incidence rates have higher mutation loads in signatures caused by bacteria-produced mutagen colibactin.

Dr. Falk Pharma, a research-based pharmaceutical company specializing in digestive and metabolic medicine, today announced positive results from its pivotal, phase 3 trial (NUC-5) on norucholic acid ...

In this valuable study, the authors demonstrate that TCF7L2 plays a role in the pathogenesis of cachexia in a mouse model of GI cancer. The results are solid, although future studies will need further ...

Researchers at Peking University have discovered that a filamentous gut fungus, Fusarium foetens, can reverse metabolic ...

David Polsky, MD, discussed a study showing ctDNA levels before melanoma treatment strongly predict recurrence and its speed, ...

Mar. 3, 2025 — Researchers have shown how a low carbohydrate diet can worsen the DNA-damaging effects of some gut microbes to cause colorectal cancer. The study compared the effects of three ...

Encompass Health tapped Patrick Tuer to serve as its first COO. He has held various leadership positions, including group ...

Most skin cancers are treatable, mainly if they're found early. Regular skin checks are an important part of your health ...

A gut toxin that’s been linked to colorectal cancers for more than two decades may be contributing to the sharp rise of the ...

It's unclear why colon cancer cases have doubled in people under 55 over the past two decades, a staggering rise that has ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.